| 0 |
DEVICE STIMULATION ISSUE |
1 |
0.0400 |
| 1 |
SECOND DEGREE CHEMICAL BURN OF SKIN |
2 |
0.0333 |
| 2 |
BURNS FOURTH DEGREE |
1 |
0.0323 |
| 3 |
BLADDER ULCER |
1 |
0.0244 |
| 4 |
BASAL GANGLIA HAEMATOMA |
1 |
0.0238 |
| 5 |
THIRD DEGREE CHEMICAL BURN OF SKIN |
1 |
0.0238 |
| 6 |
CHEMICAL INJURY |
18 |
0.0220 |
| 7 |
MASTOID EFFUSION |
1 |
0.0200 |
| 8 |
BURN INFECTION |
3 |
0.0147 |
| 9 |
APPLICATION SITE BURN |
57 |
0.0116 |
| 10 |
BURNS SECOND DEGREE |
20 |
0.0114 |
| 11 |
CHEMICAL BURN |
13 |
0.0113 |
| 12 |
SINGLE COMPONENT OF A TWO-COMPONENT PRODUCT ADMINISTERED |
1 |
0.0111 |
| 13 |
INTENTIONAL PRODUCT MISUSE TO CHILD |
1 |
0.0078 |
| 14 |
BURNS THIRD DEGREE |
8 |
0.0076 |
| 15 |
BURNS FIRST DEGREE |
2 |
0.0070 |
| 16 |
BACTERIAL ABDOMINAL INFECTION |
1 |
0.0068 |
| 17 |
MUCOSAL HYPERTROPHY |
1 |
0.0068 |
| 18 |
ORCHIDECTOMY |
1 |
0.0062 |
| 19 |
ADULT FAILURE TO THRIVE |
1 |
0.0047 |
| 20 |
VERY LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0045 |
| 21 |
APPLICATION SITE HYPOAESTHESIA |
1 |
0.0043 |
| 22 |
NIPPLE SWELLING |
1 |
0.0040 |
| 23 |
DEVICE MAINTENANCE ISSUE |
2 |
0.0034 |
| 24 |
APPLICATION SITE VESICLES |
22 |
0.0034 |
| 25 |
FROSTBITE |
1 |
0.0033 |
| 26 |
THERMAL BURN |
21 |
0.0030 |
| 27 |
INFUSION SITE INFLAMMATION |
2 |
0.0028 |
| 28 |
APPLICATION SITE PUSTULES |
1 |
0.0027 |
| 29 |
CEREBRAL ARTERIOSCLEROSIS |
1 |
0.0026 |
| 30 |
PRODUCT LABEL ON WRONG PRODUCT |
1 |
0.0025 |
| 31 |
APPLICATION SITE SCAR |
3 |
0.0024 |
| 32 |
ALVEOLAR OSTEITIS |
1 |
0.0024 |
| 33 |
INFLUENZA A VIRUS TEST POSITIVE |
1 |
0.0023 |
| 34 |
ALLERGY TO PLANTS |
1 |
0.0022 |
| 35 |
CHONDROLYSIS |
1 |
0.0021 |
| 36 |
APPLICATION SITE BRUISE |
2 |
0.0021 |
| 37 |
CHEMICAL BURN OF SKIN |
5 |
0.0020 |
| 38 |
APPLICATION SITE INFECTION |
1 |
0.0020 |
| 39 |
KELOID SCAR |
1 |
0.0019 |
| 40 |
INFUSION SITE DISCOMFORT |
2 |
0.0019 |
| 41 |
APPLICATION SITE PAIN |
40 |
0.0018 |
| 42 |
PRODUCT CLOSURE ISSUE |
1 |
0.0018 |
| 43 |
MEDICAL DEVICE SITE PAIN |
1 |
0.0018 |
| 44 |
UNINTENTIONAL USE FOR UNAPPROVED INDICATION |
1 |
0.0017 |
| 45 |
APPLICATION SITE HYPERSENSITIVITY |
2 |
0.0016 |
| 46 |
INFUSION SITE IRRITATION |
2 |
0.0016 |
| 47 |
GINGIVAL DISCOMFORT |
1 |
0.0015 |
| 48 |
SKIN DEPIGMENTATION |
2 |
0.0015 |
| 49 |
TRYPTASE INCREASED |
1 |
0.0014 |
| 50 |
ESCHAR |
1 |
0.0014 |
| 51 |
LIMB CRUSHING INJURY |
1 |
0.0013 |
| 52 |
NEGATIVISM |
1 |
0.0013 |
| 53 |
INFUSION SITE PRURITUS |
4 |
0.0013 |
| 54 |
POST-TRAUMATIC NECK SYNDROME |
1 |
0.0012 |
| 55 |
INCISION SITE HAEMORRHAGE |
1 |
0.0012 |
| 56 |
APPLICATION SITE DISCOLOURATION |
5 |
0.0012 |
| 57 |
INFUSION SITE HAEMORRHAGE |
4 |
0.0012 |
| 58 |
GLOMERULAR FILTRATION RATE INCREASED |
1 |
0.0012 |
| 59 |
HYDROTHORAX |
1 |
0.0012 |
| 60 |
INFUSION SITE OEDEMA |
1 |
0.0012 |
| 61 |
GENITAL BURNING SENSATION |
1 |
0.0012 |
| 62 |
THALAMUS HAEMORRHAGE |
1 |
0.0011 |
| 63 |
NASAL OEDEMA |
2 |
0.0011 |
| 64 |
SUSPECTED PRODUCT QUALITY ISSUE |
2 |
0.0011 |
| 65 |
SKIN GRAFT |
1 |
0.0011 |
| 66 |
HYPERVIGILANCE |
1 |
0.0010 |
| 67 |
WOUND SECRETION |
4 |
0.0010 |
| 68 |
DUST ALLERGY |
1 |
0.0010 |
| 69 |
APPLICATION SITE EXFOLIATION |
4 |
0.0010 |
| 70 |
PANCREATIC MASS |
1 |
0.0009 |
| 71 |
APPLICATION SITE SCAB |
2 |
0.0009 |
| 72 |
APPLICATION SITE ERYTHEMA |
24 |
0.0009 |
| 73 |
BACTERIAL TEST POSITIVE |
2 |
0.0009 |
| 74 |
SCAB |
10 |
0.0009 |
| 75 |
ADMINISTRATION SITE PAIN |
1 |
0.0009 |
| 76 |
HYPERTENSIVE EMERGENCY |
1 |
0.0008 |
| 77 |
PRODUCT CONTAMINATION MICROBIAL |
1 |
0.0008 |
| 78 |
INFUSION SITE WARMTH |
1 |
0.0008 |
| 79 |
POST-ACUTE COVID-19 SYNDROME |
1 |
0.0008 |
| 80 |
APPLICATION SITE SWELLING |
4 |
0.0008 |
| 81 |
APPLICATION SITE WARMTH |
1 |
0.0008 |
| 82 |
INFUSION SITE PAIN |
10 |
0.0008 |
| 83 |
OFF LABEL USE OF DEVICE |
1 |
0.0007 |
| 84 |
CHONDROPATHY |
2 |
0.0007 |
| 85 |
RHONCHI |
1 |
0.0007 |
| 86 |
APPLICATION SITE INFLAMMATION |
1 |
0.0007 |
| 87 |
INFUSION SITE ERYTHEMA |
6 |
0.0007 |
| 88 |
INFUSION SITE INDURATION |
1 |
0.0007 |
| 89 |
KNEE DEFORMITY |
1 |
0.0007 |
| 90 |
NO ADVERSE EVENT |
120 |
0.0007 |
| 91 |
SCAR |
11 |
0.0006 |
| 92 |
INFUSION SITE SWELLING |
4 |
0.0006 |
| 93 |
CYSTITIS INTERSTITIAL |
1 |
0.0006 |
| 94 |
HYPERAESTHESIA |
5 |
0.0006 |
| 95 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
11 |
0.0006 |
| 96 |
TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED |
1 |
0.0006 |
| 97 |
BLISTER |
33 |
0.0006 |
| 98 |
INJECTION SITE OEDEMA |
1 |
0.0006 |
| 99 |
SERUM FERRITIN DECREASED |
1 |
0.0006 |
| 100 |
APPLICATION SITE REACTION |
4 |
0.0006 |
| 101 |
DRUG SCREEN NEGATIVE |
1 |
0.0006 |
| 102 |
SCHIZOAFFECTIVE DISORDER |
1 |
0.0006 |
| 103 |
DEVICE ALARM ISSUE |
1 |
0.0006 |
| 104 |
ESSENTIAL HYPERTENSION |
1 |
0.0005 |
| 105 |
BLOOD IRON INCREASED |
1 |
0.0005 |
| 106 |
STENOSIS |
1 |
0.0005 |
| 107 |
TRAUMATIC HAEMORRHAGE |
1 |
0.0005 |
| 108 |
JAUNDICE NEONATAL |
1 |
0.0005 |
| 109 |
JOINT NOISE |
1 |
0.0005 |
| 110 |
MULTI-ORGAN DISORDER |
1 |
0.0005 |
| 111 |
INTERNATIONAL NORMALISED RATIO DECREASED |
2 |
0.0005 |
| 112 |
SLEEP DEFICIT |
1 |
0.0005 |
| 113 |
LIMB MASS |
1 |
0.0005 |
| 114 |
PRODUCT PACKAGE ASSOCIATED INJURY |
1 |
0.0004 |
| 115 |
NECK SURGERY |
1 |
0.0004 |
| 116 |
GASTRITIS EROSIVE |
2 |
0.0004 |
| 117 |
CARTILAGE INJURY |
1 |
0.0004 |
| 118 |
DEVICE INFUSION ISSUE |
1 |
0.0004 |
| 119 |
BURNING SENSATION |
28 |
0.0004 |
| 120 |
RADICULOPATHY |
1 |
0.0004 |
| 121 |
TEMPOROMANDIBULAR JOINT SYNDROME |
1 |
0.0004 |
| 122 |
BREAST SWELLING |
1 |
0.0004 |
| 123 |
GINGIVITIS |
2 |
0.0004 |
| 124 |
APPLICATION SITE HAEMORRHAGE |
1 |
0.0004 |
| 125 |
NERVE INJURY |
4 |
0.0004 |
| 126 |
DRUG TOLERANCE DECREASED |
1 |
0.0004 |
| 127 |
NEUTROPHIL COUNT ABNORMAL |
1 |
0.0004 |
| 128 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 129 |
PULMONARY PAIN |
1 |
0.0003 |
| 130 |
DEVICE POWER SOURCE ISSUE |
1 |
0.0003 |
| 131 |
LUMBAR SPINAL STENOSIS |
1 |
0.0003 |
| 132 |
SKIN BURNING SENSATION |
24 |
0.0003 |
| 133 |
INFUSION SITE REACTION |
1 |
0.0003 |
| 134 |
MYOSITIS |
3 |
0.0003 |
| 135 |
CHEST X-RAY ABNORMAL |
1 |
0.0003 |
| 136 |
BLOOD BLISTER |
1 |
0.0003 |
| 137 |
BILE DUCT STONE |
1 |
0.0003 |
| 138 |
SUSPECTED COVID-19 |
1 |
0.0003 |
| 139 |
PROSTATE CANCER METASTATIC |
1 |
0.0003 |
| 140 |
TERMINAL STATE |
2 |
0.0003 |
| 141 |
WRONG PRODUCT ADMINISTERED |
2 |
0.0003 |
| 142 |
APPLICATION SITE DRYNESS |
1 |
0.0003 |
| 143 |
JOINT EFFUSION |
2 |
0.0003 |
| 144 |
PRODUCT ODOUR ABNORMAL |
3 |
0.0003 |
| 145 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
3 |
0.0003 |
| 146 |
GLOSSITIS |
1 |
0.0003 |
| 147 |
FRUSTRATION |
1 |
0.0003 |
| 148 |
ASTHMATIC CRISIS |
1 |
0.0003 |
| 149 |
BLOOD PHOSPHORUS DECREASED |
1 |
0.0003 |
| 150 |
WOUND HAEMORRHAGE |
1 |
0.0003 |
| 151 |
PARANASAL SINUS HYPERSECRETION |
1 |
0.0003 |
| 152 |
SKIN ODOUR ABNORMAL |
1 |
0.0003 |
| 153 |
MUSCLE HAEMORRHAGE |
1 |
0.0002 |
| 154 |
ENURESIS |
1 |
0.0002 |
| 155 |
FRUSTRATION TOLERANCE DECREASED |
2 |
0.0002 |
| 156 |
LEG AMPUTATION |
1 |
0.0002 |
| 157 |
APPLICATION SITE IRRITATION |
3 |
0.0002 |
| 158 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 159 |
SHOULDER OPERATION |
1 |
0.0002 |
| 160 |
MUSCLE STRAIN |
2 |
0.0002 |
| 161 |
HAEMORRHAGIC ANAEMIA |
1 |
0.0002 |
| 162 |
GINGIVAL SWELLING |
1 |
0.0002 |
| 163 |
WHEELCHAIR USER |
1 |
0.0002 |
| 164 |
BUNDLE BRANCH BLOCK RIGHT |
1 |
0.0002 |
| 165 |
NEPHROPATHY |
2 |
0.0002 |
| 166 |
DEVICE OCCLUSION |
3 |
0.0002 |
| 167 |
SKIN ABRASION |
1 |
0.0002 |
| 168 |
FINGER DEFORMITY |
1 |
0.0002 |
| 169 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
6 |
0.0002 |
| 170 |
THERAPY CHANGE |
2 |
0.0002 |
| 171 |
DRUG EFFECT LESS THAN EXPECTED |
3 |
0.0002 |
| 172 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 173 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 174 |
PRODUCT SOLUBILITY ABNORMAL |
1 |
0.0002 |
| 175 |
SKIN DISCOLOURATION |
9 |
0.0002 |
| 176 |
VARICOSE VEIN |
1 |
0.0002 |
| 177 |
TENDERNESS |
2 |
0.0002 |
| 178 |
COMPRESSION FRACTURE |
1 |
0.0002 |
| 179 |
BACK INJURY |
2 |
0.0002 |
| 180 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
0.0002 |
| 181 |
ASPIRATION |
2 |
0.0002 |
| 182 |
TOOTH FRACTURE |
2 |
0.0002 |
| 183 |
HYPERKERATOSIS |
1 |
0.0002 |
| 184 |
NECK PAIN |
10 |
0.0002 |
| 185 |
APPLICATION SITE PRURITUS |
4 |
0.0002 |
| 186 |
VENTRICULAR SEPTAL DEFECT |
1 |
0.0002 |
| 187 |
MUSCULOSKELETAL DISCOMFORT |
3 |
0.0002 |
| 188 |
ENTEROCOLITIS |
1 |
0.0002 |
| 189 |
SKIN WARM |
1 |
0.0002 |
| 190 |
HYPERTRIGLYCERIDAEMIA |
1 |
0.0002 |
| 191 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 192 |
ACCIDENT |
2 |
0.0002 |
| 193 |
SKIN EXFOLIATION |
14 |
0.0002 |
| 194 |
PLATELET COUNT ABNORMAL |
1 |
0.0002 |
| 195 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 196 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 197 |
LIMB DISCOMFORT |
5 |
0.0002 |
| 198 |
SCOLIOSIS |
1 |
0.0002 |
| 199 |
CHOLANGITIS |
1 |
0.0002 |
| 200 |
MULTIPLE INJURIES |
1 |
0.0002 |
| 201 |
MUSCLE ATROPHY |
2 |
0.0002 |
| 202 |
TENDON DISORDER |
1 |
0.0002 |
| 203 |
EXPIRED PRODUCT ADMINISTERED |
5 |
0.0002 |
| 204 |
SKIN DISORDER |
5 |
0.0001 |
| 205 |
PAIN OF SKIN |
4 |
0.0001 |
| 206 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 207 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
1 |
0.0001 |
| 208 |
APPLICATION SITE RASH |
2 |
0.0001 |
| 209 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 210 |
PANIC REACTION |
1 |
0.0001 |
| 211 |
HYPERTHYROIDISM |
2 |
0.0001 |
| 212 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 213 |
SENSITIVE SKIN |
1 |
0.0001 |
| 214 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 215 |
DRUG INEFFECTIVE |
178 |
0.0001 |
| 216 |
TENDON PAIN |
1 |
0.0001 |
| 217 |
INSURANCE ISSUE |
2 |
0.0001 |
| 218 |
MATERNAL DRUGS AFFECTING FOETUS |
1 |
0.0001 |
| 219 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 220 |
DEVICE INFORMATION OUTPUT ISSUE |
1 |
0.0001 |
| 221 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 222 |
MUSCLE DISORDER |
1 |
0.0001 |
| 223 |
BACK DISORDER |
2 |
0.0001 |
| 224 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 225 |
METASTASES TO BONE |
2 |
0.0001 |
| 226 |
CANDIDA INFECTION |
2 |
0.0001 |
| 227 |
INADEQUATE ANALGESIA |
1 |
0.0001 |
| 228 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
| 229 |
MUSCULOSKELETAL PAIN |
6 |
0.0001 |
| 230 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 231 |
JOINT STIFFNESS |
3 |
0.0001 |
| 232 |
PRODUCT ADHESION ISSUE |
4 |
0.0001 |
| 233 |
HAEMARTHROSIS |
1 |
0.0001 |
| 234 |
SKIN IRRITATION |
5 |
0.0001 |
| 235 |
NERVE COMPRESSION |
1 |
0.0001 |
| 236 |
INCORRECT DRUG ADMINISTRATION DURATION |
3 |
0.0001 |
| 237 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 238 |
SPINAL DISORDER |
1 |
0.0001 |
| 239 |
RECALLED PRODUCT ADMINISTERED |
1 |
0.0001 |
| 240 |
EYE INFLAMMATION |
1 |
0.0001 |
| 241 |
CHOKING |
2 |
0.0001 |
| 242 |
HEPATOMEGALY |
1 |
0.0001 |
| 243 |
ARTHRITIS |
8 |
0.0001 |
| 244 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
2 |
0.0001 |
| 245 |
INABILITY TO AFFORD MEDICATION |
1 |
0.0001 |
| 246 |
BLOOD PRESSURE ABNORMAL |
2 |
0.0001 |
| 247 |
PRODUCT PHYSICAL ISSUE |
2 |
0.0001 |
| 248 |
HYPOTHERMIA |
1 |
0.0001 |
| 249 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 250 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 251 |
ERYTHEMA |
20 |
0.0001 |
| 252 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 253 |
HEAD INJURY |
3 |
0.0001 |
| 254 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 255 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 256 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 257 |
WOUND INFECTION |
1 |
0.0001 |
| 258 |
ANAPHYLACTIC REACTION |
5 |
0.0001 |
| 259 |
DENTAL CARIES |
1 |
0.0001 |
| 260 |
RASH PAPULAR |
2 |
0.0001 |
| 261 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 262 |
NEOPLASM |
1 |
0.0001 |
| 263 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 264 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
3 |
0.0001 |
| 265 |
NEURALGIA |
2 |
0.0001 |
| 266 |
DISCOMFORT |
5 |
0.0001 |
| 267 |
FEELING HOT |
5 |
0.0001 |
| 268 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 269 |
EYE SWELLING |
3 |
0.0001 |
| 270 |
POISONING |
1 |
0.0001 |
| 271 |
LOSS OF CONSCIOUSNESS |
10 |
0.0001 |
| 272 |
PERIPHERAL SWELLING |
12 |
0.0001 |
| 273 |
ROTATOR CUFF SYNDROME |
1 |
0.0001 |
| 274 |
HIATUS HERNIA |
1 |
0.0001 |
| 275 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 276 |
NODULE |
1 |
0.0001 |
| 277 |
BEDRIDDEN |
1 |
0.0001 |
| 278 |
BLOOD PRESSURE DECREASED |
5 |
0.0001 |
| 279 |
SWELLING |
7 |
0.0001 |
| 280 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 281 |
PRODUCT TASTE ABNORMAL |
1 |
0.0001 |
| 282 |
LIMB INJURY |
2 |
0.0001 |
| 283 |
PRODUCT QUALITY ISSUE |
10 |
0.0001 |
| 284 |
DRUG TOXICITY |
1 |
0.0001 |
| 285 |
ROAD TRAFFIC ACCIDENT |
3 |
0.0001 |
| 286 |
HAEMOPTYSIS |
2 |
0.0001 |
| 287 |
PAIN |
44 |
0.0001 |
| 288 |
WOUND |
2 |
0.0001 |
| 289 |
MASS |
1 |
0.0001 |
| 290 |
PAIN IN EXTREMITY |
21 |
0.0001 |
| 291 |
EYE PAIN |
4 |
0.0001 |
| 292 |
HYPERSENSITIVITY |
13 |
0.0001 |
| 293 |
DYSPHONIA |
4 |
0.0001 |
| 294 |
NASAL CONGESTION |
4 |
0.0001 |
| 295 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 296 |
PULMONARY MASS |
1 |
0.0001 |
| 297 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 298 |
HYPOAESTHESIA |
10 |
0.0001 |
| 299 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 300 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 301 |
DEVICE FAILURE |
1 |
0.0001 |
| 302 |
DEVICE ADHESION ISSUE |
1 |
0.0001 |
| 303 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 304 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 305 |
ANKLE FRACTURE |
1 |
0.0001 |
| 306 |
TENDONITIS |
1 |
0.0001 |
| 307 |
BACK PAIN |
15 |
0.0001 |
| 308 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 309 |
CYANOSIS |
1 |
0.0001 |
| 310 |
PRODUCTIVE COUGH |
3 |
0.0001 |
| 311 |
MOVEMENT DISORDER |
2 |
0.0001 |
| 312 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 313 |
AMNESIA |
4 |
0.0001 |
| 314 |
IMPAIRED HEALING |
2 |
0.0001 |
| 315 |
COAGULOPATHY |
1 |
0.0001 |
| 316 |
MUSCLE SPASMS |
11 |
0.0001 |
| 317 |
URINARY RETENTION |
2 |
0.0001 |
| 318 |
PERICARDITIS |
1 |
0.0001 |
| 319 |
HEMIPARESIS |
1 |
0.0001 |
| 320 |
FLUID RETENTION |
3 |
0.0001 |
| 321 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 322 |
PRODUCT USE ISSUE |
11 |
0.0001 |
| 323 |
LOCAL SWELLING |
1 |
0.0001 |
| 324 |
INJURY |
4 |
0.0001 |
| 325 |
DEPRESSED MOOD |
3 |
0.0001 |
| 326 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 327 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 328 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
4 |
0.0001 |
| 329 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 330 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
2 |
0.0001 |
| 331 |
MOBILITY DECREASED |
4 |
0.0001 |
| 332 |
ARTHRALGIA |
23 |
0.0001 |
| 333 |
TOOTHACHE |
1 |
0.0001 |
| 334 |
OSTEOMYELITIS |
1 |
0.0001 |
| 335 |
PELVIC PAIN |
1 |
0.0001 |
| 336 |
BRONCHITIS |
4 |
0.0001 |
| 337 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 338 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 339 |
URINARY TRACT INFECTION |
9 |
0.0001 |
| 340 |
GASTRIC ULCER |
1 |
0.0001 |
| 341 |
INCREASED APPETITE |
1 |
0.0001 |
| 342 |
GAIT DISTURBANCE |
10 |
0.0001 |
| 343 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 344 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 345 |
CONTUSION |
5 |
0.0001 |
| 346 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 347 |
DYSTONIA |
1 |
0.0001 |
| 348 |
EAR PAIN |
1 |
0.0001 |
| 349 |
BONE PAIN |
3 |
0.0001 |
| 350 |
DISABILITY |
1 |
0.0001 |
| 351 |
SINUS DISORDER |
1 |
0.0001 |
| 352 |
THERAPEUTIC RESPONSE DECREASED |
3 |
0.0000 |
| 353 |
INSOMNIA |
13 |
0.0000 |
| 354 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 355 |
DERMATITIS |
1 |
0.0000 |
| 356 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 357 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 358 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 359 |
DEVICE DISLOCATION |
2 |
0.0000 |
| 360 |
CONSTIPATION |
10 |
0.0000 |
| 361 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 362 |
MUSCULOSKELETAL STIFFNESS |
4 |
0.0000 |
| 363 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 364 |
NEOPLASM MALIGNANT |
3 |
0.0000 |
| 365 |
GLOSSODYNIA |
1 |
0.0000 |
| 366 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 367 |
DEVICE ISSUE |
4 |
0.0000 |
| 368 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 369 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 370 |
CHROMATURIA |
1 |
0.0000 |
| 371 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 372 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
3 |
0.0000 |
| 373 |
NEUROPATHY PERIPHERAL |
4 |
0.0000 |
| 374 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 375 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 376 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 377 |
PRURITUS |
16 |
0.0000 |
| 378 |
INFECTION |
6 |
0.0000 |
| 379 |
OEDEMA PERIPHERAL |
5 |
0.0000 |
| 380 |
LUNG DISORDER |
2 |
0.0000 |
| 381 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 382 |
ABASIA |
1 |
0.0000 |
| 383 |
DYSGEUSIA |
3 |
0.0000 |
| 384 |
CELLULITIS |
2 |
0.0000 |
| 385 |
THERAPY CESSATION |
2 |
0.0000 |
| 386 |
INFLAMMATION |
2 |
0.0000 |
| 387 |
SKIN ULCER |
1 |
0.0000 |
| 388 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 389 |
DEAFNESS |
1 |
0.0000 |
| 390 |
SPEECH DISORDER |
2 |
0.0000 |
| 391 |
INJECTION SITE BRUISING |
3 |
0.0000 |
| 392 |
INJECTION SITE HAEMORRHAGE |
3 |
0.0000 |
| 393 |
OEDEMA |
2 |
0.0000 |
| 394 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 395 |
FALL |
12 |
0.0000 |
| 396 |
ARTHROPATHY |
2 |
0.0000 |
| 397 |
MEDICATION ERROR |
2 |
0.0000 |
| 398 |
PAIN IN JAW |
1 |
0.0000 |
| 399 |
MYALGIA |
6 |
0.0000 |
| 400 |
FLATULENCE |
2 |
0.0000 |
| 401 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 402 |
HYPERSOMNIA |
1 |
0.0000 |
| 403 |
HERPES ZOSTER |
2 |
0.0000 |
| 404 |
DECREASED APPETITE |
8 |
0.0000 |
| 405 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 406 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 407 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 408 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
6 |
0.0000 |
| 409 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 410 |
JOINT SWELLING |
4 |
0.0000 |
| 411 |
EPILEPSY |
1 |
0.0000 |
| 412 |
CARDIAC DISORDER |
3 |
0.0000 |
| 413 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 414 |
DYSPNOEA |
18 |
0.0000 |
| 415 |
CYSTITIS |
1 |
0.0000 |
| 416 |
WEIGHT INCREASED |
7 |
0.0000 |
| 417 |
NIGHT SWEATS |
1 |
0.0000 |
| 418 |
RHINORRHOEA |
2 |
0.0000 |
| 419 |
PRODUCT DOSE OMISSION |
2 |
0.0000 |
| 420 |
PSORIASIS |
4 |
0.0000 |
| 421 |
EYE DISORDER |
1 |
0.0000 |
| 422 |
HEADACHE |
19 |
0.0000 |
| 423 |
ABDOMINAL PAIN |
7 |
0.0000 |
| 424 |
LIP SWELLING |
1 |
0.0000 |
| 425 |
GAIT INABILITY |
1 |
0.0000 |
| 426 |
HYPOTENSION |
6 |
0.0000 |
| 427 |
URTICARIA |
5 |
0.0000 |
| 428 |
ABDOMINAL DISCOMFORT |
5 |
0.0000 |
| 429 |
SOMNOLENCE |
6 |
0.0000 |
| 430 |
VOMITING |
14 |
0.0000 |
| 431 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 432 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 433 |
FEELING ABNORMAL |
7 |
0.0000 |
| 434 |
ILLNESS |
3 |
0.0000 |
| 435 |
RASH MACULAR |
1 |
0.0000 |
| 436 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 437 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 438 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 439 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 440 |
CRYING |
1 |
0.0000 |
| 441 |
PANIC ATTACK |
1 |
0.0000 |
| 442 |
UNDERDOSE |
2 |
0.0000 |
| 443 |
INJECTION SITE MASS |
1 |
0.0000 |
| 444 |
SEPSIS |
3 |
0.0000 |
| 445 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 446 |
ASTHMA |
3 |
0.0000 |
| 447 |
RHEUMATOID ARTHRITIS |
3 |
0.0000 |
| 448 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 449 |
DIARRHOEA |
17 |
0.0000 |
| 450 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 451 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 452 |
DIZZINESS |
13 |
0.0000 |
| 453 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 454 |
CHILLS |
3 |
0.0000 |
| 455 |
PARAESTHESIA |
4 |
0.0000 |
| 456 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 457 |
DISORIENTATION |
1 |
0.0000 |
| 458 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 459 |
DRY MOUTH |
2 |
0.0000 |
| 460 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 461 |
FATIGUE |
19 |
0.0000 |
| 462 |
OSTEOPOROSIS |
1 |
0.0000 |
| 463 |
NAUSEA |
19 |
0.0000 |
| 464 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 465 |
POLLAKIURIA |
1 |
0.0000 |
| 466 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 467 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 468 |
HYPOACUSIS |
1 |
0.0000 |
| 469 |
PYREXIA |
8 |
0.0000 |
| 470 |
RASH |
10 |
0.0000 |
| 471 |
COVID-19 |
4 |
0.0000 |
| 472 |
TACHYCARDIA |
2 |
0.0000 |
| 473 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 474 |
VISION BLURRED |
3 |
0.0000 |
| 475 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 476 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 477 |
ADVERSE EVENT |
2 |
0.0000 |
| 478 |
NASOPHARYNGITIS |
4 |
0.0000 |
| 479 |
HYPOKALAEMIA |
1 |
0.0000 |
| 480 |
RENAL DISORDER |
1 |
0.0000 |
| 481 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 482 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 483 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 484 |
MIGRAINE |
2 |
0.0000 |
| 485 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 486 |
HEART RATE INCREASED |
2 |
0.0000 |
| 487 |
PRODUCT USE IN UNAPPROVED INDICATION |
5 |
0.0000 |
| 488 |
DRY EYE |
1 |
0.0000 |
| 489 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
4 |
0.0000 |
| 490 |
SINUSITIS |
2 |
0.0000 |
| 491 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 492 |
HAEMORRHAGE |
2 |
0.0000 |
| 493 |
ECZEMA |
1 |
0.0000 |
| 494 |
PANCREATITIS |
1 |
0.0000 |
| 495 |
BRADYCARDIA |
1 |
0.0000 |
| 496 |
DRUG DEPENDENCE |
3 |
0.0000 |
| 497 |
ASTHENIA |
7 |
0.0000 |
| 498 |
PNEUMONIA |
6 |
0.0000 |
| 499 |
RASH PRURITIC |
1 |
0.0000 |
| 500 |
MALAISE |
8 |
0.0000 |
| 501 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 502 |
TREMOR |
3 |
0.0000 |
| 503 |
DEPRESSION |
4 |
0.0000 |
| 504 |
LETHARGY |
1 |
0.0000 |
| 505 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 506 |
SEIZURE |
2 |
0.0000 |
| 507 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 508 |
PALPITATIONS |
2 |
0.0000 |
| 509 |
SURGERY |
1 |
0.0000 |
| 510 |
WHEEZING |
1 |
0.0000 |
| 511 |
CATARACT |
1 |
0.0000 |
| 512 |
IRRITABILITY |
1 |
0.0000 |
| 513 |
CONDITION AGGRAVATED |
5 |
0.0000 |
| 514 |
CHEST PAIN |
3 |
0.0000 |
| 515 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 516 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 517 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 518 |
SWELLING FACE |
1 |
0.0000 |
| 519 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 520 |
COUGH |
4 |
0.0000 |
| 521 |
SLEEP DISORDER |
1 |
0.0000 |
| 522 |
ANXIETY |
4 |
0.0000 |
| 523 |
EPISTAXIS |
1 |
0.0000 |
| 524 |
HALLUCINATION |
1 |
0.0000 |
| 525 |
HOT FLUSH |
1 |
0.0000 |
| 526 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 527 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 528 |
HOSPITALISATION |
2 |
0.0000 |
| 529 |
DRUG INTERACTION |
2 |
0.0000 |
| 530 |
THROMBOSIS |
1 |
0.0000 |
| 531 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 532 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 533 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 534 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 535 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 536 |
BALANCE DISORDER |
1 |
0.0000 |
| 537 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 538 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 539 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 540 |
WEIGHT DECREASED |
3 |
0.0000 |
| 541 |
DYSPHAGIA |
1 |
0.0000 |
| 542 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 543 |
ALOPECIA |
2 |
0.0000 |
| 544 |
DYSPEPSIA |
1 |
0.0000 |
| 545 |
SYNCOPE |
1 |
0.0000 |
| 546 |
INJECTION SITE PAIN |
3 |
0.0000 |
| 547 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 548 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 549 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 550 |
OFF LABEL USE |
8 |
0.0000 |
| 551 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 552 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 553 |
DEATH |
7 |
0.0000 |
| 554 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 555 |
HYPERHIDROSIS |
1 |
0.0000 |
| 556 |
DRY SKIN |
1 |
0.0000 |
| 557 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 558 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 559 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |